tiprankstipranks
Trending News
More News >
Akzo Nobel NV (NL:AKZA)
:AKZA

Akzo Nobel NV (AKZA) AI Stock Analysis

Compare
9 Followers

Top Page

NL:AKZA

Akzo Nobel NV

(AKZA)

Select Model
Select Model
Select Model
Neutral 63 (OpenAI - 5.2)
Rating:63Neutral
Price Target:
€63.00
▲(13.51% Upside)
Action:ReiteratedDate:02/05/26
The score is primarily driven by improving profitability/cash generation and gradual deleveraging, tempered by weak recent revenue momentum and still-elevated leverage. Technicals are moderately supportive and valuation is reasonable with an attractive dividend yield.
Positive Factors
Diversified business model
Akzo Nobel's two-segment model (decorative paints, performance coatings, specialty chemicals) delivers exposure to retail, industrial and construction end markets. That diversification reduces reliance on any single cycle, stabilizes revenue sources and supports long-term innovation and channel breadth.
Improving margins
Meaningful margin improvement in 2025 reflects better pricing, cost mix and operating leverage. Sustained higher margins boost cash generation potential and resilience to input-cost swings, enabling steadier investment, R&D and capacity to support dividends or debt paydown over the medium term.
Stronger cash generation and deleveraging trend
Rebounded free cash flow and positive FCF growth indicate improved cash conversion versus prior years. Combined with a downward trend in total debt since 2022, this enhances the firm's ability to fund operations, service obligations and selectively invest or return capital over coming quarters.
Negative Factors
Weak revenue momentum
Persistent flat-to-declining top-line restricts the company's ability to scale fixed-cost leverage and sustain long-term growth. Without renewed revenue traction, margin gains may be harder to maintain and strategic initiatives could face budget constraints, limiting medium-term upside.
Elevated leverage
Although leverage is falling, debt-to-equity near 1.0x remains high versus earlier years, reducing balance-sheet flexibility. Elevated debt increases interest and refinancing exposure, constraining M&A, capex and the firm's ability to absorb industry downturns without curtailing strategic investments.
Cash-flow volatility & limited debt coverage
Volatile operating and free cash flow, including a negative FCF year, undermines predictability of capital allocation and slows deleveraging. Low OCF coverage versus debt means incremental cash generation is largely needed for interest and repayments, limiting flexibility in weaker market conditions.

Akzo Nobel NV (AKZA) vs. iShares MSCI Netherlands ETF (EWN)

Akzo Nobel NV Business Overview & Revenue Model

Company DescriptionAkzo Nobel N.V. engages in the production and sale of paints and coatings worldwide. It offers decorative paints, including paints, lacquers, and varnishes; and a range of mixing machines and color concepts for the building and renovation industry, as well as specialty coatings for metal, wood, and other building materials. The company also provides performance coatings that protect and enhance ships, cars, aircraft, yachts, architectural components, consumer goods, and oil and gas facilities. It offers its products primarily under Dulux, International, Sikkens, and Interpon brands. The company was formerly known as Akzo NV and changed its name to Akzo Nobel N.V. in 1994. Akzo Nobel N.V. was founded in 1646 and is headquartered in Amsterdam, the Netherlands.
How the Company Makes MoneyAkzo Nobel generates revenue primarily through the sale of its paints, coatings, and specialty chemicals. The company's revenue model is based on both direct sales to customers and partnerships with distributors. Key revenue streams include decorative paints for retail customers, performance coatings for industrial applications, and specialty chemicals for various sectors, including automotive and construction. Significant partnerships with industry players enhance its market presence and facilitate innovation. Additionally, Akzo Nobel benefits from a strong focus on sustainability and innovation, which drives demand for its eco-friendly products and solutions.

Akzo Nobel NV Financial Statement Overview

Summary
Profitability and cash generation improved in 2025, and leverage has been trending down since 2022. Offsetting this are flat-to-declining recent revenue, multi-year earnings/cash-flow volatility, and still-elevated debt-to-equity (~1.04x) that limits flexibility.
Income Statement
63
Positive
Revenue has been broadly flat to slightly down over the last three years (2025: -2.37% after near-flat 2024 and a small decline in 2023), suggesting limited top-line momentum. Profitability improved meaningfully in 2025 versus 2024 (net margin ~6.3% vs ~5.1%; EBITDA margin ~15.2% vs ~13.1%), indicating better cost/price mix and operating leverage. However, earnings are still below the stronger 2020–2021 level (2021 net margin ~8.6%), highlighting a multi-year margin reset and some cyclicality/volatility in operating profit.
Balance Sheet
58
Neutral
Leverage is elevated for a specialty chemicals profile: debt-to-equity is ~1.04x in 2025, though it has improved from ~1.36x in 2022 and ~1.29x in 2023. Equity has been relatively stable while total debt has trended down since 2022, which is a constructive deleveraging path. Returns on equity are solid and improving (ROE ~13.6% in 2025 vs ~11.8% in 2024), but the balance sheet still carries above-average leverage versus 2020–2021 (when debt-to-equity was ~0.50–0.65x), leaving less flexibility if industry conditions soften.
Cash Flow
60
Neutral
Cash generation rebounded in 2025 with operating cash flow of ~€915M and free cash flow of ~€606M, and free cash flow growth of +12.43%. Free cash flow covered a meaningful portion of earnings in 2025 (free cash flow ~66% of net income), improving versus 2024 (~55%), but still below 2023 (~75%) and 2020 (~79%). Cash flow has also been volatile across the period (notably negative free cash flow in 2022), and operating cash flow remains a modest fraction of the company’s debt load (coverage ~0.22x in 2025), which keeps debt reduction capacity somewhat constrained.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue10.16B10.71B10.67B10.85B9.59B
Gross Profit4.05B4.34B4.23B3.92B3.85B
EBITDA1.54B1.40B1.41B1.05B1.53B
Net Income635.00M542.00M442.00M352.00M829.00M
Balance Sheet
Total Assets13.95B14.25B14.56B14.74B13.88B
Cash, Cash Equivalents and Short-Term Investments1.92B1.47B1.78B1.79B1.21B
Total Debt5.06B5.37B5.56B5.88B3.55B
Total Liabilities9.13B9.43B10.01B10.19B8.24B
Stockholders Equity4.66B4.57B4.32B4.33B5.42B
Cash Flow
Free Cash Flow606.00M362.00M834.00M-29.00M317.00M
Operating Cash Flow915.00M741.00M1.21B291.00M605.00M
Investing Cash Flow424.00M-132.00M-144.00M-1.09B-134.00M
Financing Cash Flow-964.00M-684.00M-827.00M1.14B-974.00M

Akzo Nobel NV Technical Analysis

Technical Analysis Sentiment
Negative
Last Price55.50
Price Trends
50DMA
59.25
Negative
100DMA
58.22
Negative
200DMA
58.42
Negative
Market Momentum
MACD
-0.31
Positive
RSI
31.44
Neutral
STOCH
20.59
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:AKZA, the sentiment is Negative. The current price of 55.5 is below the 20-day moving average (MA) of 59.70, below the 50-day MA of 59.25, and below the 200-day MA of 58.42, indicating a bearish trend. The MACD of -0.31 indicates Positive momentum. The RSI at 31.44 is Neutral, neither overbought nor oversold. The STOCH value of 20.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NL:AKZA.

Akzo Nobel NV Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
€4.47B20.9914.32%2.83%6.09%-7.18%
63
Neutral
€9.48B4.231.39%3.38%-2.03%-89.67%
59
Neutral
€1.06B14.408.84%3.50%-3.45%-5.55%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
53
Neutral
€2.75B283.16-0.24%5.41%-2.24%-102.76%
52
Neutral
€13.77B-2.823.61%4.46%
49
Neutral
€960.05M-55.266.84%1.46%9.94%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NL:AKZA
Akzo Nobel NV
55.40
-2.51
-4.33%
NL:AMG
AMG ADVANCED METALLURGICAL GROUP NV
35.50
20.58
137.98%
NL:APAM
Aperam S.A.
40.00
10.53
35.75%
NL:CRBN
Corbion NV
18.92
-0.48
-2.50%
NL:IMCD
IMCD N.V.
71.70
-63.13
-46.82%
NL:DSFIR
DSM-Firmenich AG
57.50
-38.24
-39.94%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 05, 2026